Journal of Pediatric Health Care
Volume 18, Issue 6 , Pages 320-322 , November 2004

Constipation: an overview of treatment

  • Heidi Van Orden, PharmD

      Affiliations

    • Corresponding Author InformationReprints not available from author
    • Heidi Van Orden is Senior Clinical Pharmacist at the Center for Cancer and Blood Disorders, Children's Medical Center, Dallas, Texas.

References 

    References
  1. Bishop W. Miracle laxative?. Journal of Pediatric. Gastroenterology and Nutrition. 2001;32:514–515
  2. Kurz A, Sessler DI. Opioid-induced bowel dysfunction. Drugs. 2003;63:649–671
  3. Lexi-Drugs (Complete + Specialties). (2004). Lexi-Comp Inc. Retrieved August 1, 2004, from www.lexi.com
  4. McDonald, L. (2002, February). Oral naloxone reduces opioid-induced constipation. Hem/Onc Today. Retrieved October 5, 2004, from http://www.hemonctoday.com/200202/frameset.asp?article=naloxone.asp
  5. Schmidt WK. Alvimopan (ADL 8-2698) is a novel peripheral opioid antagonist. American Journal of Surgery. 2001;18(Suppl. 5A):27–38

☆ SECTION EDITORJuanita Conkin Dale, PhD, RN, CPNPChildren's Medical Center of DallasDallas, Texas

PII: S0891-5245(04)00267-6

doi: 10.1016/j.pedhc.2004.08.003

Journal of Pediatric Health Care
Volume 18, Issue 6 , Pages 320-322 , November 2004

Article Tools